Cargando…
Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death, and its incidence is increasing worldwide in an alarming manner. The development of curative therapy for advanced and metastatic HCC is a high clinical priority. The HCC genome is complex and heterogeneous; therefore, the ide...
Autores principales: | ZIMONJIC, DRAZEN B., POPESCU, NICHOLAS C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583004/ https://www.ncbi.nlm.nih.gov/pubmed/22580498 http://dx.doi.org/10.3892/ijo.2012.1474 |
Ejemplares similares
-
DLC-1:a Rho GTPase-activating protein and tumour suppressor
por: Durkin, Marian E, et al.
Publicado: (2007) -
DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions
por: Tripathi, Veenu, et al.
Publicado: (2014) -
DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017) -
Acquired genetic and functional alterations associated with transforming growth factor β type I resistance in Hep3B human hepatocellular carcinoma cell line
por: Zimonjic, Drazen B, et al.
Publicado: (2009) -
Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma
por: Wang, Fang, et al.
Publicado: (2021)